Business Association Chemistry Pharma Life Sciences

Innovation

OECD Study: Counterfeits are costing Switzerland dearly

In a video statement (only in German), scienceindustries Director Dr. Stephan Mumenthaler talks about the results of the OECD Counterfeiting Study and how our members help to track down the origin of counterfeit products and remove them from circulation.

23.03.2021

More on the subject


Swiss innovation needs an efficient patent system

Further links


Medie Release Stop Piracy

Downloads


OECD study ‘Counterfeiting, Piracy and the Swiss Economy’ Brochure: «Counterfeiting, Piracy and the Swiss Economy»
Innovation

ERI Dispatch 2025-20: strategic priorisation is necessary

Innovation

Intellectual property needs protection at an international level

Innovation

Switzerland: a hotspot for innovation and patents

Innovation

Science and industry: a symbiosis that fosters innovation

Innovation

The life sciences sector as a solid foundation of the Swiss economy

Innovation

Swiss Biotech Report 2023: Industry as a driver of innovation

Innovation

WTO decision on TRIPS Agreement

Innovation

Biotech vaccine against dangerous respiratory syncytial virus (RSV)

Innovation

Looking back on our 140th anniversary

Innovation

Innovations of today and tomorrow

Innovation

140 years of innovation are just the beginning

Innovation

Focus on social and environmental responsibility

Innovation

Chemical and pharmaceutical industry as a driver of growth

Innovation

Products for our quality of life

Innovation

About the beginnings of “chemicals” in Switzerland

Innovation

Interview Stephan Mumenthaler: success factors to boost R&D

Close
News

Newsletter subscription

scienceindustries News
Standpoints
Point
 
 

Foreign trade statistics chemistry pharma life science

Further analyzes

Export Chemicals Pharma Life Sciences Switzerland by region

Further analyzes